« Back
Home /
HEC96719

HEC96719

Item no.	DCC-DC60775-5mg
Manufacturer	DCChemicals
CASRN	2181834-03-5
Amount	5 mg
Quantity options	10 mg 25 mg 5 mg
Category	In Vivo
Applications	IV
Specific against	other
Smiles	ClC1C=CC=C(C=1C1C(COC2C=CC3=C(C4(CC5C=CC(C(=O)O)=CC=5O3)CC4)N=2)=C(C2CC2)ON=1)Cl
Available
Manufacturer - Applications	HEC96719 is a tricyclic farnesoid X receptor agonist (FXR agonist) for treatment of non-alcoholic steatohepatitis. HEC96719 exhibits excellent potency superior to GW4064 and obeticholic acid in in vitro and in vivo assays of FXR activation. It also shows higher FXR selectivity and more favorable tissue distribution dominantly in liver and intestine. Preclinical data on pharmacokinetic properties, efficacy, and safety profiles overall indicate that HEC96719 is a promising drug candidate for NASH treatment.
Molecular Weight	549, 404

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Delivery expected until 12/11/2025

Compare

Add to wishlist

Get an offer

Request delivery time